Paulex Bio
La Jolla, US · Founded 2023 · Delaware corporation · 2 known investors
Founders & leadership
SM
Sanjuan MiguelChief Executive Officer
Board
ER
Edgardo RayoBoard director
MH
Mohammad HayatBoard director
FL
Francisco LeonBoard director
Investors · 2
Also in the syndicate · 2
Lifespan Vision VenturesMDB Capital
Reported raises · per SEC filings
Form D private placements$18.5M disclosed across 1 round · 2025
▶$18.5MraisedDec 2025 · 163 investors · PharmaceuticalsRule 506(c)
▶$18.5MraisedDec 2025 · 163 investors · Pharmaceuticals
Rule 506(c)Officers, directors & promoters on the filing
- Edgardo RayoDirector
- Mohammad HayatDirector
- Francisco LeonDirector
- Sanjuan MiguelExecutive Officer, Director
- Offering amount
- $22.5M
- Amount sold
- $18.5M
- Sales commissions
- $1.6M
- Placement agents
- MDB Capital
- First sale
- Nov 2025
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06c
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
MDB Capital Holdings (MDBH) Q2 2026 Earnings Call: Leaner Costs and Core Asset Focustradingkey.com · Aug 2026Frequently asked questions
- How much funding has Paulex Bio raised?
- Paulex Bio has disclosed $18.5M raised across 1 round.
- Where is Paulex Bio headquartered?
- Paulex Bio is headquartered in La Jolla, US.